Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-κB/Caspase-3 Pathways

MLA

Guo J, et al. “Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-ΚB/Caspase-3 Pathways.” Drug Design, Development and Therapy, vol. ume 15, Oct. 2021, pp. 4339–58. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.7a257901e8504ff0807084fdcfa40934&authtype=sso&custid=ns315887.

APA

Guo J, Li J, Wei H, & Liang Z. (2021). Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-κB/Caspase-3 Pathways. Drug Design, Development and Therapy, ume 15, 4339–4358.

Chicago

Guo J, Li J, Wei H, and Liang Z. 2021. “Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-ΚB/Caspase-3 Pathways.” Drug Design, Development and Therapy ume 15 (October): 4339–58. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.7a257901e8504ff0807084fdcfa40934&authtype=sso&custid=ns315887.